Pure GLP-1 agonists such as semaglutide do not reliably move LDL
placebo based on their pre-existing level of DR
This is the period where the effects of Retatrutide compound, and the data starts to get very interesting
Typically, those who should avoid GLP-1s are those with: A personal or family history of certain thyroid cancers Multiple endocrine neoplasia syndrome type 2 A history of pancreatitis Severe gastroparesis (delayed stomach emptying) Pregnancy or plans to become pregnant Additionally, if you have a history of eating disorders, severe depression or unrealistic weight loss expectations, its important to address these concerns with your physician before considering medication
The number will increase as we see the medication go into pill format, says nutritionist and regulatory expert Claire Baseley
Tirzepatide with vitamin B12 and tirzepatide with glycine are formulations that some compounding pharmacies offer, aiming to support energy and metabolic function during weight loss
